10x Genomics (NASDAQ: TXG), a biotechnology company that designs and manufactures gene sequencing technology, was listed following its IPO in September. While the stock saw some volatility post its debut, it currently trades at about $65, a ~65% increase from its IPO price of $39 per share...
10x Genomics (NASDAQ: TXG), a biotechnology company that designs and manufactures gene sequencing technology, was listed following its IPO in September. While the stock saw some volatility post its debut, it currently trades at about $65, a ~65% increase from its IPO price of $39 per share...
Share this Article
Recommended